SEIZURE
dr. RETNO JAYANTRI KETAREN, SpS
BLOK NEUROBEHAVIOUR
BANGKITAN / KEJANG
Kompetensi Dokter Umum (SKDI, 2012)
STATUS
EPILEPTIKUS
EPILEPSI
Bangkitan / Kejang
Kejang/Bangkitan epileptik :
Terjadinya tanda / gejala yang
bersifat sesaat akibat aktifitas
neuronal yang abnormal dan
berlebihan di otak
Engel J, Pedley TA.Chapter 1. Epilepsy: a comprehensive textbook. 2nd edition. Philadelphia: Lippincott
Williams & Wilkins, 2008
+
EPILEPSY
BANGKITAN ?
ACUTE SYMPTOMATIC SEIZURE
NOT
REAL ?
+
+ TATALAKSANA EPILEPSI
Level of confidence :
A: efektif sebagai monoterapi ; B sangat mungkin efektif sebagai monoterapi ;
C mungkin efektif sebagai monoterapi ; D berpotensi untuk efektif sebagai
monoterapi
+ TATALAKSANA EPILEPSI
START LOW
GO SLOW
+ TATALAKSANA EPILEPSI
CARBAMAZEPINE
+
DOSIS :
10 – 20 mg/kgBB
n Sindroma Steven-Johnson,
n Lupus-like syndrome
DOSIS :
5 -8 mg/kgBB
n Sindrom Steven-Johnson
n Anemia aplastik
n Hipertrofi gusi
DOSIS :
2 - 4 mg/kgBB
n Hepatotoksik
n Sindrom Steven-Johnson
DOSIS :
15-40
mg/kgBB
n Hepatotoksisitas,
n Hiperamonemia
n Leukopenia, trombositipenia
n Pankreatitis
Paling sering
digunakan Dosis : 342 – 360 Loading dose :
mg 400 mg
melalui NGT
Anak-anak : dosis
inisial à 20
mg/kg/hari, dosis
mingguan
ditingkatkan hingga 10
mg/kg/hari.
Zheng F et al. Levetiracetam for the treatment of status epilepticus. Expert Rev. Neurother. 15(10), 1113–1121 (2015)
Swisher C et al. Use of pregabalin for nonconvulsive seizures and nonconvulsive status epilepticus. Seizure 22 (2013) 116–118
Suttichaimongkol T, et al. The efficacy of topiramate in status epilepticus, experience from Thailand. Neurology Asia 2012; 17(4) : 297 – 302
+
SEIZURE
?
REAL ?
NOT REAL ?
+
SEIZURE ?
+
BANGKITAN ?
T
H
A
N
K
YOU
FOCAL ONSET AWARE MOTORIC
FOCAL ONSET IMPAIRED AWARENESS MOTORIC
GENERALIZED ONSET MOTORIC : MYOCLONIC
GENERALIZED ONSET NON-MOTORIC : ABSANCE
FOCAL ONSET TO BILATERAL TONIC CLONIC
GENERALIZED ONSET : ATONIC
GENERALIZED ONSET : TONIC CLONIC
SPECIAL CASES
5 X HALF LIFE
CBZ 0 – 0 – 1/2
CBZ 0 – 0 – 1
CBZ 1/2 – 0 – 1
CBZ 1 – 0 – 1
AEDS PHARMACOKINETICS
PHARMACOKINETICS
AEDS PHARMACOKINETICS
AEDS PHARMACOKINETICS
INTERACTIONS WITH NEW AEDS
OAE Tabel 6.Interaksi Farmokinetik antar-obat anti epilepsi (OAE) 18
TAMBAHAN OAE YANG TERKENA DAMPAK INTERAKSI
CBZ CLB CZP ESM GBP LAM LE OXC PB PHT PRM TPM VPA VGB TGB ZNS
V
CARBAMAZEPIN AI ¯CLB ¯CZP ¯ ESM O ¯LAM O O O /¯¯ ¯PRM ¯ TPM ¯¯VPA O ¯TGB ¯ZNS
CLOBAZAM ¯CB - O O O O O O PB PHT ¯PRM O VPA O O O
CLONAZEPAM Z O - O O O O O O /¯PHT O O O O O O
GABAPENTIN O O O O - O O O O /¯PHT O O ¯¯ O O O
LAMOTRIGINE O O O O O - O O O PHT O ? O O O O
LEVETIRACETA O O O O O O - O O O O O O O O O
M O O O O O ¯LAM O - O O O O O O O O
OXCARBAZEPIN O ¯CBZ ¯CZP ¯ESM O ¯¯LAM O - O NCP ¯¯TPM O O ¯TGB ¯ZNS
E AI ¯CBZ ¯CZP ¯ESM O ¯¯LAM O OXC PB /¯¯ /¯ ¯¯TPM ¯¯ O ¯TGB ¯ZNS
PHENOBARBITA ¯CB ¯CBZ ¯CZP ¯ESM O ¯¯LAM O O NCP PHT PRM ¯¯TPM VPA O O O
L Z O O O O O O O O - - - ¯¯ O O O
PHENYTOIN ¯CB O O /¯ O /¯ O O PB /¯¯ O ¯TPM VPA O O O
PRIMIDONE Z ESM LAM O PHT PRM ¯¯
TOPIRAMATE O PHT VPA
VALPROATE /¯¯ ¯¯
CBZ PHT VPA
E -